Evidence map›Paper›PMID 42254137›Full record

ArticleAnnals of medicine and surgery (2012)2026

Comparative efficacy of ceftolozane-tazobactam versus ceftazidime-avibactam for

Asim Shah, Syeda Vilay Zehra Rizvi, Javeria Nawaz, Hammad Saif, Syeda Umme Abiha Rizvi, Diya Rathi, Sabika Fatima, Suleman Khan, Aizaz Anwar Khalid, Sajjad Ghanim Al Badri and 1 more

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Asim ShahDepartment of Medicine, Khyber Medical College, Peshawar, Pakistan.
Syeda Vilay Zehra RizviDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Javeria NawazDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Hammad SaifDepartment of Medicine, Khyber Medical College, Peshawar, Pakistan.
Syeda Umme Abiha RizviDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Diya RathiDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Sabika FatimaDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Suleman KhanDepartment of Medicine, Khyber Medical College, Peshawar, Pakistan.
Aizaz Anwar KhalidDepartment of Medicine, Peshawar Medical College, Peshawar, Pakistan.
Sajjad Ghanim Al BadriDepartment of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
Rubaiyat Tasfin TalukderMymensingh Medical College Hospital, Mymensingh, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infections caused by multidrug-resistant/difficult-to-treat (MDR/DTR) Methods: We performed a systematic review and meta-analysis, evaluated by Grading of Recommendations Assessment, Development, and Evaluation (GRADE), of comparative observational studies that included hospitalized adults with confirmed MDR/DTR Results: Six observational cohorts ( Conclusions: In current comparative cohorts, C/T and C/A show similar outcomes for severe MDR/DTR

Indexed as

avibactamceftazidimeceftolozanemultidrug resistancePseudomonas aeruginosatazobactam

Identifiers

PMID42254137
PMCPMC13236363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.